Teladoc Health, Inc. (TDOC) NYSE
7.91
+0.3(+3.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.91
+0.3(+3.94%)
Currency In USD
| Market Cap | 1.23B |
| Enterprise Value | 1.49B |
| P/E Ratio | -8.28 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0.57 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 0.68 |
| Enterprise/EBITDA | 26.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.07 |
| Operating Margin | -0.08 |
| Return On Assets | -0.06 |
| Return On Equity | -0.12 |
| Revenue | 2.53B |
| Revenue/Share | 14.04 |
| Gross Profit | 1.76B |
| EBITDA | 147.3M |
| Net Income | -200.32M |
| Diluted EPS | -1.14 |
| Total Cash | 750.74M |
| Total Cash/Share | 4.19 |
| Total Debt | 1.03B |
| Total Debt/Equity | 0.77 |
| Current Ratio | 2.8 |
| Book Value Per Share | 7.46 |
| 52-Week Change | 15.14 |
| 52-Week High | 9.77 |
| 52-Week Low | 4.4 |
| Moving Average 50 Days | 6.07 |
| Moving Average 200 Days | 6.8 |
| Average Volume | 4.97M |
| Shares Outstanding | 180.51M |
| % Held by Institutions | 81.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |